I am often asked “who on earth would oppose a treaty to facilitate access to information and knowledge to people with reading disabilities?” Please read my selected quotes from the comments posted today on the Copyright office page here. But I would also like to highlight some really positive and supporting comments about the treaty. There are more of them than the negative ones but do they have the same weight?
Continue Reading →
November 9, 2009
Senator Patrick Leahy, Chairman
Senator Jeff Sessions, Ranking Member
Senate Judiciary Committee
Senator Max Baucus, Chairman
Senator Chuck Grassley, Ranking Member
Senate Finance Committee
Representative John Conyers, Chairman
Representative Lamar Smith, Ranking Member
House Committee on the Judiciary
Representative Henry Waxman, Chairman,
Representative Joe Barton, Ranking Member
House Committee on Energy and Commerce
Representative Charles Rangel, Chairman
Representative Dave Camp, Ranking Member
House Committee on Ways and Means
Continue Reading →
While the 6th Round of negotiations of the Anti-Counterfeiting Trade Agreement (ACTA) is taking place in Seoul, Republic of Korea from November 4-6, 2009, the 5th session of the WIPO Advisory Committee on Enforcement (ACE) met from November 2-4, 2009.
Continue Reading →
The final stretch of 2009 ushers in a host of meetings at Geneva based institutions including the WIPO Advisory Committee on Enforcement, the WIPO Committee on Development and Intellectual Property, the WTO Ministerial, the WHO Expert Working Group and the Standing Committee on Copyright. To keep abreast of the hive of activity emanating from WIPO, WHO and WTO, here is a roadmap to keep track of the various meetings.
November 2, 2009
African-Arab Seminar on Copyright Limitations and Exceptions: Addressing the Needs of Affected Constituencies
Continue Reading →
On October 12, 2009, the “Industry Government Forum on Access to Medicines” (IGFAM) was launched. The UK Minister for International Development, MP Mike Foster made a a speech to launch this initiative which is reproduced below.
Presentations were also made by Pfizer (Ponni Subbiah), GSK (Abbas Hussain), Rajiv Venkayya (Gates Foundation), Prashant Yadav (Massachusetts Institute of Technology) and Suerie Moon (Research Fellow and Doctoral Candidate, Kennedy School of Government, Harvard University).
Continue Reading →
The Wellcome Trust convened an “Opinion Formers Conference” on “Counterfeit Medicines: Perspectives and Action” on Monday 26 October 2009. Continue Reading →
KEI, Richard Stallman, ORG, letter to European Commission opposing Oracle acquisition of MySQL assets from Sun The following is a letter that KEI, Richard Stallman and ORG have sent to the European Commission, asking the European Commission to prevent Oracle… Continue Reading →
110th CONGRESS, 1st Session
S. 2210
To provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.
IN THE SENATE OF THE UNITED STATES
October 19, 2007
Mr. SANDERS introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
Continue Reading →
The following are some listserves run by KEI:
- A2K : Access to Knowledge
- IP-Health : Intellectual Property Rights and Healthcare
Continue Reading →
On November 4-6, 2009, the next round of negotiations for the Anti-Counterfeiting Trade Negotiations (ACTA) will take place in Seoul, Korea. The following is another strange chapter in the secrecy surrounding this negotiation.
Background
Since ACTA was first announced, KEI has pressed the negotiating governments to provide more transparency, including recently, for example